The present invention relates to methods of selectively modulating (for example inhibiting) the activity of histone deacetylase 6 and/or 8 (HDAC6 and/or HDAC8), and treating HDAC6 and/or HDAC8 associated diseases, including, for example, cancers, inflammatory disorders, and neurodegenerative disorders.